JULIAN BAKER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JULIAN BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JULIAN BAKER. JULIAN BAKER is Director in INCYTE CORP ($INCY) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in XOMA Corp ($XOMA) and 10% Owner in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in GENOMIC HEALTH INC ($GHDX).
Latest Insider Trading Transactions of JULIAN BAKER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GHDX, IDRA, INCY, GEVA, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Buy | P | 3.75 | 4,898,409 | 18,369,034 | 6,323,855 | 1.4 M to 6.3 M (+343.64 %) |
Feb 17 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Buy | P | 3.75 | 434,924 | 1,630,965 | 625,495 | 190.6 K to 625.5 K (+228.22 %) |
Jan 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 94.19 | 1,000,000 | 94,190,000 | 9,184,771 | 8.2 M to 9.2 M (+12.22 %) |
Jan 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 4.90 | 3,927 | 19,242 | 54,128 | 50.2 K to 54.1 K (+7.82 %) |
Jan 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 4.90 | 3,927 | 19,242 | 1,425,446 | 1.4 M to 1.4 M (+0.28 %) |
Jan 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 4.90 | 3,927 | 19,242 | 190,571 | 186.6 K to 190.6 K (+2.10 %) |
Oct 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.16 | 8,914 | 19,254 | 50,201 | 41.3 K to 50.2 K (+21.59 %) |
Oct 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.16 | 8,914 | 19,254 | 1,421,519 | 1.4 M to 1.4 M (+0.63 %) |
Oct 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.16 | 8,914 | 19,254 | 186,644 | 177.7 K to 186.6 K (+5.02 %) |
Jul 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.83 | 6,182 | 17,495 | 41,287 | 35.1 K to 41.3 K (+17.61 %) |
Jul 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.83 | 6,182 | 17,495 | 1,412,605 | 1.4 M to 1.4 M (+0.44 %) |
Jul 03 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.83 | 6,182 | 17,495 | 177,730 | 171.5 K to 177.7 K (+3.60 %) |
May 29 2014 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | A | 49.01 | 15,000 | 735,150 | 15,000 | |
May 23 2014 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 7.02 | 10,000 | 70,200 | 0 | |
May 23 2014 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 7.02 | 10,000 | 70,200 | 0 | |
May 23 2014 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 7.02 | 10,000 | 70,200 | 0 | |
May 23 2014 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 7.02 | 10,000 | 70,200 | 390,839 | 380.8 K to 390.8 K (+2.63 %) |
May 23 2014 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 7.02 | 10,000 | 70,200 | 12,465,783 | 12.5 M to 12.5 M (+0.08 %) |
May 23 2014 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 7.02 | 10,000 | 70,200 | 2,058,937 | 2 M to 2.1 M (+0.49 %) |
Jun 11 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 3.25 | 70,000 | 227,500 | 70,000 | |
Mar 07 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 105.75 | 9,031 | 955,028 | 211,614 | 202.6 K to 211.6 K (+4.46 %) |
Mar 07 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 105.75 | 365,969 | 38,701,222 | 8,172,521 | 7.8 M to 8.2 M (+4.69 %) |
Mar 19 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 6.06 | 80,000 | 484,800 | 80,000 | |
Mar 12 2014 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 5.82 | 60,000 | 349,200 | 60,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 127,000 | 1,114,425 | 892,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 4,567,000 | 40,075,425 | 31,967,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 1,084,000 | 9,512,100 | 7,587,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 2,459,000 | 21,577,725 | 1,019,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 88,153,000 | 773,542,575 | 36,534,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | D | 8.78 | 20,922,000 | 183,590,550 | 8,671,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 170,000 | 8,798,860 | 6,050,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 6,830,000 | 353,507,140 | 243,450,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 242,000 | 12,525,436 | 5,880,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 9,758,000 | 505,054,564 | 236,620,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 61,000 | 3,157,238 | 5,638,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 2,439,000 | 126,237,762 | 226,862,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 121,000 | 6,262,718 | 5,577,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 4,879,000 | 252,527,282 | 224,423,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 5,456,000 | 282,391,648 | 5,456,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 219,544,000 | 11,363,158,352 | 219,544,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 25,000,000 | 1,293,950,000 | 25,000,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 133,000 | 6,883,814 | 5,674,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 5,367,000 | 277,785,186 | 228,326,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 85,000 | 4,399,430 | 5,541,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 3,415,000 | 176,753,570 | 222,959,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 5,456,000 | 282,391,648 | 5,456,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 219,544,000 | 11,363,158,352 | 219,544,000 | |
Nov 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | P | 51.76 | 25,000,000 | 1,293,950,000 | 25,000,000 | |
Sep 27 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 56.63 | 25,663 | 1,453,296 | 202,583 | 176.9 K to 202.6 K (+14.51 %) |
Sep 27 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 56.63 | 1,024,337 | 58,008,204 | 7,806,552 | 6.8 M to 7.8 M (+15.10 %) |
Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 4.44 | 10,000 | 44,400 | 10,000 | |
Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 4.44 | 10,000 | 44,400 | 10,000 | |
Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 4.44 | 10,000 | 44,400 | 10,000 | |
Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 4.44 | 10,000 | 44,400 | 380,839 | 370.8 K to 380.8 K (+2.70 %) |
Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 4.44 | 10,000 | 44,400 | 12,455,783 | 12.4 M to 12.5 M (+0.08 %) |
Jun 13 2013 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 4.44 | 10,000 | 44,400 | 2,048,937 | 2 M to 2 M (+0.49 %) |
Jan 08 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 47.53 | 20,099 | 955,305 | 176,920 | 156.8 K to 176.9 K (+12.82 %) |
Jan 08 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 47.53 | 839,621 | 39,907,186 | 6,782,215 | 5.9 M to 6.8 M (+14.13 %) |
Oct 31 2012 | XOMA | XOMA Corp | BAKER JULIAN | Director | Buy | P | 3.00 | 103,608 | 310,824 | 463,839 | 360.2 K to 463.8 K (+28.76 %) |
Oct 31 2012 | XOMA | XOMA Corp | BAKER JULIAN | Director | Buy | P | 3.00 | 4,282,419 | 12,847,257 | 17,888,512 | 13.6 M to 17.9 M (+31.47 %) |
Oct 31 2012 | XOMA | XOMA Corp | BAKER JULIAN | Director | Buy | P | 3.00 | 336,639 | 1,009,917 | 1,922,230 | 1.6 M to 1.9 M (+21.23 %) |
Jul 13 2012 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 41.20 | 21,082 | 868,578 | 156,821 | 135.7 K to 156.8 K (+15.53 %) |
Jul 13 2012 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 41.20 | 864,918 | 35,634,622 | 5,942,594 | 5.1 M to 5.9 M (+17.03 %) |
Aug 03 2012 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 5.67 | 10,000 | 56,700 | 0 | |
Aug 03 2012 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 5.67 | 10,000 | 56,700 | 66,340 | 56.3 K to 66.3 K (+17.75 %) |
Jun 06 2012 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 6.66 | 5,000 | 33,300 | 0 | |
Jun 06 2012 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 6.66 | 5,000 | 33,300 | 5,000 | 0 to 5 K |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.94 | 380 | 12,518 | 247,063 | 246.7 K to 247.1 K (+0.15 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.94 | 17,026 | 560,882 | 9,086,690 | 9.1 M to 9.1 M (+0.19 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.21 | 2,732 | 87,992 | 246,683 | 244 K to 246.7 K (+1.12 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.04 | 546 | 17,493 | 243,951 | 243.4 K to 244 K (+0.22 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.21 | 122,268 | 3,938,008 | 9,069,664 | 8.9 M to 9.1 M (+1.37 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.04 | 24,454 | 783,479 | 8,947,396 | 8.9 M to 8.9 M (+0.27 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.46 | 517 | 17,815 | 243,405 | 242.9 K to 243.4 K (+0.21 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.46 | 23,104 | 796,111 | 8,922,942 | 8.9 M to 8.9 M (+0.26 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.25 | 1,972 | 67,541 | 242,888 | 240.9 K to 242.9 K (+0.82 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.11 | 540 | 17,882 | 240,916 | 240.4 K to 240.9 K (+0.22 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.47 | 555 | 19,129 | 240,376 | 239.8 K to 240.4 K (+0.23 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.25 | 88,028 | 3,014,959 | 8,899,838 | 8.8 M to 8.9 M (+1.00 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.11 | 24,136 | 799,237 | 8,811,810 | 8.8 M to 8.8 M (+0.27 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.47 | 24,769 | 853,726 | 8,787,674 | 8.8 M to 8.8 M (+0.28 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.92 | 3,212 | 108,951 | 239,821 | 236.6 K to 239.8 K (+1.36 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.67 | 897 | 30,198 | 236,609 | 235.7 K to 236.6 K (+0.38 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.59 | 370 | 12,058 | 235,712 | 235.3 K to 235.7 K (+0.16 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 31.53 | 175 | 5,517 | 235,342 | 235.2 K to 235.3 K (+0.07 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.92 | 143,388 | 4,863,721 | 8,762,905 | 8.6 M to 8.8 M (+1.66 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.67 | 40,073 | 1,349,070 | 8,619,517 | 8.6 M to 8.6 M (+0.47 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.59 | 16,526 | 538,558 | 8,579,444 | 8.6 M to 8.6 M (+0.19 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 31.53 | 7,797 | 245,824 | 8,562,918 | 8.6 M to 8.6 M (+0.09 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 30.22 | 627 | 18,946 | 235,167 | 234.5 K to 235.2 K (+0.27 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 30.22 | 26,033 | 786,621 | 8,555,121 | 8.5 M to 8.6 M (+0.31 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.98 | 214 | 6,415 | 234,540 | 234.3 K to 234.5 K (+0.09 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.98 | 8,867 | 265,807 | 8,529,088 | 8.5 M to 8.5 M (+0.10 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.86 | 1,402 | 41,861 | 234,326 | 232.9 K to 234.3 K (+0.60 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.86 | 58,198 | 1,737,699 | 8,520,221 | 8.5 M to 8.5 M (+0.69 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.90 | 460 | 13,752 | 232,924 | 232.5 K to 232.9 K (+0.20 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.90 | 19,087 | 570,615 | 8,462,023 | 8.4 M to 8.5 M (+0.23 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.50 | 116 | 3,306 | 232,464 | 232.3 K to 232.5 K (+0.05 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.90 | 1,737 | 50,196 | 232,348 | 230.6 K to 232.3 K (+0.75 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.41 | 172 | 4,886 | 230,611 | 230.4 K to 230.6 K (+0.07 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.50 | 4,811 | 137,101 | 8,442,936 | 8.4 M to 8.4 M (+0.06 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.90 | 72,073 | 2,082,773 | 8,438,125 | 8.4 M to 8.4 M (+0.86 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.41 | 7,124 | 202,358 | 8,366,052 | 8.4 M to 8.4 M (+0.09 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.28 | 536 | 15,159 | 230,439 | 229.9 K to 230.4 K (+0.23 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.25 | 754 | 21,300 | 229,903 | 229.1 K to 229.9 K (+0.33 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.28 | 22,241 | 629,011 | 8,358,928 | 8.3 M to 8.4 M (+0.27 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.25 | 31,273 | 883,431 | 8,336,687 | 8.3 M to 8.3 M (+0.38 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.28 | 722 | 20,419 | 1,488,539 | 1.5 M to 1.5 M (+0.05 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.25 | 1,014 | 28,644 | 1,487,817 | 1.5 M to 1.5 M (+0.07 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.00 | 5 | 140 | 229,149 | 229.1 K to 229.1 K (0.00 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 27.99 | 369 | 10,330 | 229,144 | 228.8 K to 229.1 K (+0.16 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.03 | 935 | 26,208 | 228,775 | 227.8 K to 228.8 K (+0.41 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.00 | 188 | 5,264 | 8,305,414 | 8.3 M to 8.3 M (0.00 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 27.99 | 14,078 | 394,112 | 8,305,226 | 8.3 M to 8.3 M (+0.17 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.03 | 35,727 | 1,001,424 | 8,291,148 | 8.3 M to 8.3 M (+0.43 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.00 | 7 | 196 | 1,486,803 | 1.5 M to 1.5 M (0.00 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 27.99 | 514 | 14,389 | 1,486,796 | 1.5 M to 1.5 M (+0.03 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.03 | 1,305 | 36,579 | 1,486,282 | 1.5 M to 1.5 M (+0.09 %) |
Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | 10% Owner | Grant | A | 0.00 | 135,462 | 0 | 144,082 | 8.6 K to 144.1 K (+1,571.48 %) |
Page: 1